To Kirk J. Leister for opening the pharmaceutical industry’s door to me.
To Charles E. Wenner for being my teacher and mentor.
To Edward McNiff for being a role model, colleague, and friend.
To Benjamin Gilad for showing me that being gutsy is glorious.
To Glyn Jones for believing in this project.
To the biopharmaceutical executives who participated in this book: your courage and vision keep me optimistic about the future of our industry.